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Abstract
Glaucoma is the leading cause of blindness in individuals of African descent (AD). While open
angle glaucoma (OAG) disproportionately affects individuals of AD compared to persons of
European descent (ED); the physiological mechanisms behind this disparity are largely unknown.
The more rapid progression and greater severity of the disease in persons of AD further raises the
concern for identifying these underlying differences in disease pathophysiology between AD and
ED glaucoma patients. Ocular structural differences between AD and ED patients, including larger
optic disc area, cup:disc ratio and thinner corneas have been found. AD individuals are also
disproportionately affected by systemic vascular diseases including: hypertension, cardiovascular
disease, stroke and diabetes mellitus. Abnormal ocular blood flow has been implicated as a risk
factor for glaucoma, and pilot research is beginning to identify localized ocular vascular
differences between AD and ED OAG patients. Given the known systemic vascular deficits and
the relationship between glaucoma and ocular blood flow, exploring these concepts in terms of
glaucoma risk factors may have a significant impact in elucidating the mechanisms behind the
disease disparity in the AD population.
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INTRODUCTION
Glaucoma is a multifactorial disease that results in progressive death of retinal ganglion cells
and loss of visual fields. Studies have shown that open angle glaucoma (OAG)
disproportionately affects people of African descent (AD) over those of European descent
(ED) and is a leading cause of blindness in persons of AD (Hyman et al. 2001; Congdon et
al. 2004; Friedman et al. 2004). Furthermore, it has a younger age of onset, progresses more
rapidly and occurs with greater severity in the AD population (Wilensky et al. 1978; Martin
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et al 1985; Wilson et al. 1985; Sommer et al. 1991; Tielsch et al 1991; Racette et al. 2003;
Racette et al. 2010). Glaucoma has been noted to affect up to six times more people of AD
than those of ED (Congdon et al 2004; Friedman et al. 2004). Moreover, the Ocular
Hypertensive Treatment study described African-American race as a baseline factor that
predicted increased risk of developing OAG (Gordon et al. 2002). Disparities in occurrence
and progression between AD and ED groups have heightened interest in the mechanisms
driving the observed disparity in OAG.
While etiology of OAG has yet to be fully described, elevated intra-ocular pressure (IOP)
has been identified as a significant and currently only treatable risk factor. However, many
patients develop glaucoma progression despite reduced IOP, while others do not develop
glaucoma despite elevated IOP (Heijl et al. 2002). This suggests other factors are involved
in OAG onset and progression (Harris et al. 2008), including compromised vascular health.
Several large population-based studies have shown that decreased ocular perfusion pressure
(OPP) has been linked to OAG prevalence, incidence and progression (Tielsch et al. 1995;
Quigley et al 2001; Bonomi et al. 2000; Leske et al. 2002; Moore et al. 2008). Multiple
small prospective studies have shown that blood flow deficiencies in retinal, choroidal, and
retrobulbar circulations are associated with OAG (Yin et al. 1997; Galassi et al 1998; Chung
et al. 1999). Specifically, studies have revealed an association of visual field defects with
decreased blood flow velocities and increased resistivity indices of the ophthalmic and short
posterior ciliary arteries (Galassi et al. 2003; Martinez et al 2005). These data indicate the
potential importance of investigating ocular vascular differences between patients of AD and
ED as a potential mechanism to explain glaucoma disease disparity.
Just as ED and AD patients differ in glaucoma development and progression, these two
groups also differ in number of systemic vascular complications. Systemic vascular
abnormalities, such as arterial hypertension, optic disc hemorrhage, and aging of the
vasculature may contribute to and be indicative of ocular vascular compromise (Harris et al.
2008; Moore et al. 2008). People of AD have been reported to have higher rates of arterial
hypertension (Racette et al. 2003), which may explain their increased rates of stroke (Sacco
et al. 1998) and cardiovascular disease (CVD) (Farquhar et al. 1990; Ferdinand 2008).
Those of AD have also been reported to have higher rates of diabetes, which is known to
have vascular complications (Sample et al. 2009).
The possible relationship between systemic and localized vascular pathology and glaucoma
onset and progression in persons of AD may be a contributory mechanism to the observed
disease disparity. This paper will review functional, structural and vascular differences of
ocular and systemic parameters between persons of AD and ED to better elucidate possible
racial differences in glaucoma pathogenesis. We hope this will allow clinicians and
researchers to consider and better understand the possible driving forces behind the
disproportionate OAG vision loss experienced by persons of AD.
MATERIALS AND METHODS
PubMed and Google Scholar searches were conducted through May 7, 2013 with the
following keywords: glaucoma, African descent, ocular blood flow, diabetes, cardiovascular
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disease, stroke and ocular perfusion pressure. References from all relevant articles found
were also reviewed to capture all pertinent articles.
VISUAL FIELD DIFFERENCES
Data from the prospective African Descent and Glaucoma Evaluation Study (ADAGES)
showed that individuals of AD perform significantly worse than people of ED on all tests of
visual function. Despite a younger average age, patients of AD in this study displayed worse
mean deviation and pattern standard deviation and more abnormal points on total and pattern
deviation plots compared to their ED counterparts. (Racette et al. 2010). In a retrospective
analysis of black and white glaucoma patients, Wilson et al. noted that visual field loss and
disc damage were worse in eyes of black patients at initial diagnosis. They also noted
greater progression of visual field loss and disk damage in black patients (Wilson et al.
1985). Furthermore, it has been suggested that the association between age and visual field
defects is stronger in persons of AD over persons of ED (Quigley et al. 1996). It is highly
important to examine why persons of AD have worse visual outcomes compared to their ED
counterparts despite similar IOP and available treatment options. Racette et al. hypothesize
that the lower visual field performance noted in patients of AD could be due to multiple
factors including detection of early visual field loss, lack of ancestry specific normative
databases for various visual field tests, genetic diversity, genetic drift, environmental and/or
socioeconomic factors; the importance of long term follow-up of patients in this study was
emphasized by the authors. (Racette et al. 2010). While these studies indicate a disparity in
visual field within AD patients, there is not an investigated mechanism to explain these
outcomes. In this paper we will review literature concerning ocular and systemic vascular
differences, as well as structural differences in persons of AD and ED in an attempt to
explore possible mechanisms other than IOP that may be contributing to this disparity in
visual outcome.
OCULAR STRUCTURAL DIFFERENCES AND INTRAOCULAR PRESSURE
Several ocular structural differences in AD and ED OAG patients have been discussed in
literature. Studies have shown differences in optic disc structure between AD and ED
groups. Significantly, larger optic disc area (Girkin et al. 2010), cup:disc ratio (C/D ratio)
(Beck et al. 1985; Martin et al 1985; Chi et al. 1989; Higginbotham et al. 2004) and deeper
maximum cup depth in those of AD (Beck et al. 1985; Mikelberg et al. 1995; Girkin et al.
2003; Racette et al. 2003; Girkin et al. 2005;) were found. In fact, the Barbados Eye Study
reported C/D ratio to be positively linked with IOP (Leske et al. 1997). OAG patients of AD
also tend to have thinner corneas (Racette et al. 2005; Haseltine et al. 2012), a known risk
factor for OAG.
Currently, there is inconsistency in data regarding differences in IOP between individuals of
AD and ED. Some studies attribute the increased prevalence and incidence of OAG in
persons of AD to elevated IOP (Leske et al. 2002; Shimmyo et al. 2003; Girkin et al. 2005;
Racette et al. 2005). In black patients in the Barbados Eye Study, Leske et al. identified a
25-fold increase in adjusted relative risk of OAG in patients with IOP greater than 25 mmHg
over those with IOP less than or equal to 17mmHg (Leske et al. 2002). However, more
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recent studies which have examined AD and ED OAG patient groups have reported no
overall differences for mean IOP between AD and ED individuals (Sample et al. 2009;
Siesky et al. 2013). It is worth noting that analyses from the Barbados, Rotterdam, and
Baltimore studies demonstrated that hypertension is associated with increased IOP and thus
may explain group differences in IOP data (Hennis et al. 2003; Racette et al. 2003; Wu and
Leske 1997). While these differences in IOP and structure have been reported, there is no
clear indication of their role in explaining glaucoma disparity within patients of AD.
OCULAR PERFUSION PRESSURE AND SYSTEMIC BLOOD PRESSURE
Studies have demonstrated a significantly higher incidence of arterial hypertension in
persons of AD compared to ED (Wu and Leske 1997; Racette et al. 2003; Hennis et al.
2003; Sample et al. 2009; Siesky et al. 2013). In fact, Hall et al. reported people of AD have
the highest prevalence of hypertension among any race regardless of geographic location
(Hall et al. 1997). However, despite the reported higher frequency of systemic hypertension
among people of AD, Sample et al. did not find differences in IOP between racial groups
(Sample et al. 2009). Leske et al. presented predictors of OAG progression from the
Barbados Eye Study, which consisted predominately of patients of AD, including lower
systolic blood pressure (SBP) and systolic OPP (Leske et al. 2007). Importantly, lower OPP
more than doubled the risk of developing OAG (Leske et al. 2008). Furthermore, the
Rotterdam Eye study reported patients with an OPP less than 50 mmHg had four times the
risk of developing OAG as those with 80mmHg (Hulsman et al. 2007).
As OPP is partially dependent on SBP, the relationship between each of these parameters
and the development and/or progression of OAG is complex and results presented
throughout the literature are varied. Many studies have found a positive correlation with
SBP and IOP in patients with OAG (Dielmans et al. 1995; Tielsch et al. 1995; Bonomi et al.
2000; Klein et al. 2005; Yip et al. 2007). Deokule and Weinreb reported that each 10 mm
Hg baseline SBP increase led to a mean 0.23 mm Hg to 0.31 mm Hg rise in IOP in OAG
patients. They reported such a positive correlation to be present in all races, as such a
relationship was found in studies that specifically investigated ED patients, AD patients and
patients of Asian descent (Deokule and Weinreb 2008). In OAG patients, each 10 mm Hg
DBP increase from baseline led to a 0.19 to 0.6 mm Hg IOP increase (Deokule and Weinreb
2008). However, they suggested that blood pressure may be more strongly correlated with
OHT than with OAG. Each 10 mm Hg SBP increase (OR = 1.20) and DBP increase (OR =
1.38) was associated with 20-30% increase in OHT prevalence. On the other hand, each 10
mm Hg increase in SBP and DBP had an odds ratio for OAG of 1.08 to 1.12 and 1.00 to
1.09, respectively. They suggested perhaps there is a SBP threshold that must be met to
affect OAG prevalence (Deokule and Weinreb 2008).
SYSTEMIC VASCULAR DIFFERENCES IN AD VS ED
Cardiovascular Disease and Stroke
Cardiovascular disease occurs in higher rates in persons of AD. According to the American
Heart Association, the death rate per 100,000 persons for cardiovascular disease was 28.7
for white males, 39.0 for black males, 20.1 for white females, and 27.7 for black females
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(Roger et al. 2012). In addition to having higher rates, people of AD also have an earlier
onset and higher severity of cardiovascular disease. This is significantly affected by risk
factors such as obesity, smoking, and a sedentary lifestyle (Ferdinand 2008). Siesky et al.
also reported significantly higher heart rates in OAG patients of AD compared to ED
(Siesky et al. 2013). Increased heart rate, in addition to arterial hypertension, is considered a
risk factor for cardiovascular disease (Chambless et al. 2003, McGruder et al. 2004).
A difference between AD and ED populations also exists in stroke rates. People of AD have
a 2.5-fold increase in stroke incidence compared to ED (Sacco et. al 1998; Howard et al.
2013). Howard et al. suggest that the disparity may be attributed to higher SBP and DBP, as
well as poorer control of arterial blood pressure. In the Reasons for Geographic and Racial
Differences in Stroke (REGARDS) study, after a 4.5 year follow up, Howard et al. reported
a 10-mm Hg difference in SBP was associated with an 8% increase in stroke risk in whites
but a 24% increase in stroke risk in for blacks (Howard et al. 2013). As both hypotension
and hypertension have been associated with OAG (Weinreb and Harris, 2009), uncontrolled
blood pressure may be a contributing factor to insufficient ocular perfusion in AD and ED
OAG patients.
Atherosclerosis
Endothelial dysfunction and atherosclerosis also contribute to dysfunctional vascular
regulation. Atherosclerosis, a chronic and progressive disease that affects many vascular
beds, including the ocular circulation (Davies 1990), is the result of deposited lipids,
inflammatory cells, and connective tissue within arterial walls. Buildup eventually leads to
plaque formation and obstruction of flow (Davies et al. 2004). Endothelial cell dysfunction
has been described as the first detectable change in atherosclerotic vessels (Behrendt &
Ganz 2002). Many of the risk factors that account for the racial disparity of cardiovascular
disease are also risk factors for atherosclerosis, including smoking, hypertension, diabetes,
dietary patterns, and physical inactivity (Luscher et al. 1993, Agyemang et al. 2009). A
higher risk of cardiovascular disease, a known risk factor of OAG (Higginbotham et al.
2004), may also be present within the ocular vasculature and may contribute to the
difference in OAG risk between AD and ED persons.
Diabetes Mellitus
Evidence has also shown that individuals of AD differ from those of ED with respect to
diabetes mellitus (DM). ADAGES reported their AD group to have higher prevalence of
DM, that, although was not significant, approached significance (p=0.10) (Girkin et al.
2010). Moreover, although cardiovascular disease is not specific to diabetes, it is more
prevalent among patients with type 1 or type 2 DM than among those without DM
(Krolewski et al. 1987; Laing et al. 2003). Dysfunction of vascular regulation has also been
shown in patients with DM (Triggle and Ding 2010), which may be apparent within the
eye's vascular system. Both diabetic and glaucoma patients have been shown to have
dysfunction in endothelial factors responsible for maintaining vascular tone (Shoshani et al.
2012).
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Given the higher rates of diabetes and vascular complications in persons of AD, a better
understanding of the diabetes, ocular vascular dysregulation and their relationship to
glaucoma is imperative. Earlier studies have shown a correlation between DM and OAG
(Becker 1971, Wilson et al. 1987), whereas more recent studies that exclude IOP as a
criterion for OAG (Foster et al. 2002) found no increased OAG risk in diabetics (Quigley et
al. 2001, Bonomi et al. 2000, Friedman et al. 2006). Moreover, the Ocular Hypertension
Treatment Study reported that early diabetes protects against the development of OAG
(Gordon et al. 2002), a finding that has since been questioned (Coleman et al. 2008).
However, eyes of diabetic patients have exhibited more cross-linking of collagen through
glycation (Goh and Cooper 2008), and it is suggested that such increased stiffness of the
cornea and sclera reduces strain at the optic nerve head resulting from IOP-induced stress in
the eye wall and thus limits damage (Quigley 2009). Since diabetes may cause vascular
dysregulation and have neurotoxic effects that contribute to glaucoma progression (Shoshani
et al. 2012), it is important to clarify how diabetes may be involved in patients of AD with
OAG.
OCULAR (LOCALIZED) VASCULAR DEFICIENCY
In addition to systemic vascular compromise and low OPP, persons of AD may have other
OAG vascular risk related factors including ischemia (Nickells 1996, Kyhn et al. 2009) and
vascular dysregulation (Tielsch et al. 1995; Bonomi et al. 2000; Leske et al. 2002) although
these have not been specifically investigated in the AD population. A recent retrospective
study by Siesky et al. investigated ocular blood flow differences between AD and ED
persons with OAG providing some of the first data to support these concepts. Results
revealed statistically significant lower retrobulbar blood flow velocities in AD patients
compared to ED patients. Reductions in peak systolic velocity in the ophthalmic artery
(p=0.0001), central retinal artery (p=0.010) and nasal and temporal short posterior ciliary
arteries (p<0.0001 and p=0.0037, respectively) were found in those of AD compared to ED.
Lower ophthalmic artery end diastolic velocity (p=0.0008) was also found in patients of AD.
These differences were found despite statistically similar IOP (Siesky et al. 2013). Similarly,
a newly published prospective study by Adeyinka et al measured retrobulbar blood flow
velocities in African patients with OAG in Nigeria and found reduced peak systolic and end
diastolic velocities and increased resistivity in the ophthalmic and central retinal arteries of
OAG patients compared to controls (Adeyinka et al 2013). Previous studies have
demonstrated a reduction in blood flow velocities in the retrobulbar vessels of glaucoma
patients in general (Sergott et al. 1994; Nicolela et al. 1996; Chiou et al. 1999; Akarsu and
Bilgili 2004; Abegão Pinto L et al 2012), and lower retrobulbar blood flow within in OAG
patients of AD may be a mechanism which contributes to their OAG disease disparity.
Importantly, vascular resistance of retrobulbar vessels has been shown to predict visual field
progression (Martinez et al. 2005); similarly, constricted blood flow has been associated
with visual field loss (Galassi et al. 2003). It is important to note that while these studies on
retrobulbar blood flow using color Doppler imaging are of great value, there are limitations
to this methodology. These limitations include variability in measured parameters, inter-
observer variability, and the inability to precisely measure vessel diameter, and therefore
determine volumetric flow (Stalmans et al. 2011).
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Despite those limitations, however, these studies suggest that persons of AD may be at a
higher risk for vascular deficits contributing to OAG compared to persons of ED and in part
may explain the differences in disease onset and progression.
CONCLUSION
Despite increased OAG incidence, prevalence and progression in individuals in AD over ED
counterparts, the mechanisms accounting for disparity between the two groups have yet to
be elucidated. Non-pressure dependent differences in ocular blood flow between people of
AD and ED are beginning to be reported (Siesky et al. 2013) and may help identify the
contributing mechanisms to this disease disparity. Persons of AD are known to have higher
incidence of hypertension and other systemic vascular diseases, such as CVD, stroke, and
diabetes. Many studies have shown an association between systemic vascular health and
OAG, yet the exact relationship of these systemic vascular complications to ocular vascular
health has not been defined. The mechanisms behind the disparity of OAG disease in
persons of AD may involve the ocular vasculature, and further prospective investigation is
highly suggested.
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